PATENT CLAIM ANALYSIS

Application Number: 15883130
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "172100"]

Abstract:
The present invention relates to an anti-CSF-1R antibody and binding fragments thereof, DNA encoding the same, host cells comprising said DNA and methods of expressing the antibody or binding fragment in a host cell. The present invention also extends to pharmaceutical compositions comprising the antibody or a binding fragment thereof and use of the antibody, binding fragment and compositions comprising the same in treatment.

Claim (Index 5):
A process for the production of an antibody, comprising culturing the host cell of  claim 4  and isolating the antibody.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.91667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14914676', '15577035', '15036209', '15305157', '15743764']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.69843011391193
- 35 USC 102 Novelty (BERT): 0.6054515062463215
- Combined Prediction Score: 0.6891322531453692
- Mean Citation Score: 369.273806
- Max Citation Score: 633.3211
- Similarity Product: 430.7478551224352

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test